Literature DB >> 26718338

MicroRNA-34a Negatively Regulates Efferocytosis by Tissue Macrophages in Part via SIRT1.

Alexandra L McCubbrey1, Joshua D Nelson2, Valerie R Stolberg3, Pennelope K Blakely4, Lisa McCloskey2, William J Janssen5, Christine M Freeman6, Jeffrey L Curtis7.   

Abstract

Apoptotic cell (AC) clearance (efferocytosis) is an evolutionarily conserved process essential for immune health, particularly to maintain self-tolerance. Despite identification of many recognition receptors and intracellular signaling components of efferocytosis, its negative regulation remains incompletely understood and has not previously been known to involve microRNAs (miRs). In this article, we show that miR-34a (gene ID 407040), well recognized as a p53-dependent tumor suppressor, mediates coordinated negative regulation of efferocytosis by resident murine and human tissue macrophages (Mø). The miR-34a expression varied greatly between Mø from different tissues, correlating inversely with their capacity for AC uptake. Transient or genetic knockdown of miR-34a increased efferocytosis, whereas miR-34a overexpression decreased efferocytosis, without altering recognition of live, necrotic, or Ig-opsonized cells. The inhibitory effect of miR-34a was mediated both by reduced expression of Axl, a receptor tyrosine kinase known to recognize AC, and of the deacetylase silent information regulator T1, which had not previously been linked to efferocytosis by tissue Mø. Exposure to AC downregulated Mø miR-34a expression, resulting in a positive feedback loop that increased subsequent capacity to engulf AC. These findings demonstrate that miR-34a both specifically regulates and is regulated by efferocytosis. Given the ability of efferocytosis to polarize ingesting Mø uniquely and to reduce their host-defense functions, dynamic negative regulation by miR-34a provides one means of fine-tuning Mø behavior toward AC in specific tissue environments with differing potentials for microbial exposure.
Copyright © 2016 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26718338      PMCID: PMC4724467          DOI: 10.4049/jimmunol.1401838

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  91 in total

1.  SIRT inhibitors induce cell death and p53 acetylation through targeting both SIRT1 and SIRT2.

Authors:  Barrie Peck; Chun-Yuan Chen; Ka-Kei Ho; Paolo Di Fruscia; Stephen S Myatt; R Charles Coombes; Matthew J Fuchter; Chwan-Deng Hsiao; Eric W-F Lam
Journal:  Mol Cancer Ther       Date:  2010-04-06       Impact factor: 6.261

2.  Lovastatin enhances clearance of apoptotic cells (efferocytosis) with implications for chronic obstructive pulmonary disease.

Authors:  Konosuke Morimoto; William J Janssen; Michael B Fessler; Kathleen A McPhillips; Valeria M Borges; Russell P Bowler; Yi-Qun Xiao; Jennifer A Kench; Peter M Henson; R William Vandivier
Journal:  J Immunol       Date:  2006-06-15       Impact factor: 5.422

3.  Loss of the RhoGAP SRGP-1 promotes the clearance of dead and injured cells in Caenorhabditis elegans.

Authors:  Lukas J Neukomm; Andreas P Frei; Juan Cabello; Jason M Kinchen; Ronen Zaidel-Bar; Zhong Ma; Lisa B Haney; Jeff Hardin; Kodi S Ravichandran; Sergio Moreno; Michael O Hengartner
Journal:  Nat Cell Biol       Date:  2010-12-19       Impact factor: 28.824

4.  Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1.

Authors:  Joseph T Rodgers; Carlos Lerin; Wilhelm Haas; Steven P Gygi; Bruce M Spiegelman; Pere Puigserver
Journal:  Nature       Date:  2005-03-03       Impact factor: 49.962

5.  SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase.

Authors:  Xiuyun Hou; Shanqin Xu; Karlene A Maitland-Toolan; Kaori Sato; Bingbing Jiang; Yasuo Ido; Fan Lan; Kenneth Walsh; Michel Wierzbicki; Tony J Verbeuren; Richard A Cohen; Mengwei Zang
Journal:  J Biol Chem       Date:  2008-05-14       Impact factor: 5.157

6.  The receptor tyrosine kinase MerTK activates phospholipase C gamma2 during recognition of apoptotic thymocytes by murine macrophages.

Authors:  Jill C Todt; Bin Hu; Jeffrey L Curtis
Journal:  J Leukoc Biol       Date:  2004-01-02       Impact factor: 4.962

7.  Inhibition by red wine extract, resveratrol, of cytokine release by alveolar macrophages in COPD.

Authors:  S V Culpitt; D F Rogers; P S Fenwick; P Shah; C De Matos; R E K Russell; P J Barnes; L E Donnelly
Journal:  Thorax       Date:  2003-11       Impact factor: 9.139

8.  SIRT1 deacetylates and positively regulates the nuclear receptor LXR.

Authors:  Xiaoling Li; Songwen Zhang; Gil Blander; Jeanette G Tse; Monty Krieger; Leonard Guarente
Journal:  Mol Cell       Date:  2007-10-12       Impact factor: 17.970

Review 9.  Tyro3 receptor tyrosine kinases in the heterogeneity of apoptotic cell uptake.

Authors:  Jeffrey L Curtis; Jill C Todt; Bin Hu; John J Osterholzer; Christine M Freeman
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01

10.  Efferocytosis impairs pulmonary macrophage and lung antibacterial function via PGE2/EP2 signaling.

Authors:  Alexandra I Medeiros; Carlos H Serezani; Sang Pyo Lee; Marc Peters-Golden
Journal:  J Exp Med       Date:  2009-01-05       Impact factor: 14.307

View more
  14 in total

1.  miR-125b controls monocyte adaptation to inflammation through mitochondrial metabolism and dynamics.

Authors:  Isabelle Duroux-Richard; Christine Roubert; Meryem Ammari; Jessy Présumey; Joachim R Grün; Thomas Häupl; Andreas Grützkau; Charles-Henri Lecellier; Valérie Boitez; Patrice Codogno; Johanna Escoubet; Yves-Marie Pers; Christian Jorgensen; Florence Apparailly
Journal:  Blood       Date:  2016-10-04       Impact factor: 22.113

2.  Mesenchymal stem cells confer resistance to doxorubicin-induced cardiac senescence by inhibiting microRNA-34a.

Authors:  Wenzheng Xia; Meng Hou
Journal:  Oncol Lett       Date:  2018-04-23       Impact factor: 2.967

Review 3.  Osteoclastic microRNAs and their translational potential in skeletal diseases.

Authors:  Kazuki Inoue; Shinichi Nakano; Baohong Zhao
Journal:  Semin Immunopathol       Date:  2019-10-07       Impact factor: 9.623

4.  Tat-Mediated Induction of miRs-34a & -138 Promotes Astrocytic Activation via Downregulation of SIRT1: Implications for Aging in HAND.

Authors:  Guoku Hu; Ke Liao; Lu Yang; Gurudutt Pendyala; Yeonhee Kook; Howard S Fox; Shilpa Buch
Journal:  J Neuroimmune Pharmacol       Date:  2017-02-24       Impact factor: 4.147

Review 5.  Senescence: Pathogenic Driver in Chronic Obstructive Pulmonary Disease.

Authors:  Melissa Rivas; Gayatri Gupta; Louis Costanzo; Huma Ahmed; Anne E Wyman; Patrick Geraghty
Journal:  Medicina (Kaunas)       Date:  2022-06-17       Impact factor: 2.948

Review 6.  MicroRNAs as Regulators of Phagocytosis.

Authors:  Wojciech Gierlikowski; Barbara Gierlikowska
Journal:  Cells       Date:  2022-04-19       Impact factor: 7.666

Review 7.  Activators of SIRT1 in the kidney and protective effects of SIRT1 during acute kidney injury (AKI) (effect of SIRT1 activators on acute kidney injury).

Authors:  Alireza Raji-Amirhasani; Mohammad Khaksari; Fatemeh Darvishzadeh Mahani; Zahra Hajializadeh
Journal:  Clin Exp Nephrol       Date:  2021-03-29       Impact factor: 2.801

Review 8.  MicroRNAs-Dependent Regulation of PPARs in Metabolic Diseases and Cancers.

Authors:  Dorothea Portius; Cyril Sobolewski; Michelangelo Foti
Journal:  PPAR Res       Date:  2017-01-12       Impact factor: 4.964

Review 9.  Non-Canonical Cell Death Induced by p53.

Authors:  Atul Ranjan; Tomoo Iwakuma
Journal:  Int J Mol Sci       Date:  2016-12-09       Impact factor: 5.923

Review 10.  Relevance of SIRT1-NF-κB Axis as Therapeutic Target to Ameliorate Inflammation in Liver Disease.

Authors:  Estefanía de Gregorio; Anna Colell; Albert Morales; Montserrat Marí
Journal:  Int J Mol Sci       Date:  2020-05-29       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.